| Assay ID | Title | Year | Journal | Article |
|---|
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1866559 | Inhibition of MAPK/ERK signalling pathway in human A2058 cells harbouring BRAF V600E and PTEN deletion mutant coexpressing ERK-KTR fused mScarlett fluorophore incubated for 2 hrs by high-content screening microscopic analysis | 2022 | Journal of natural products, 04-22, Volume: 85, Issue:4
| High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma. |
| AID1866560 | Inhibition of PI3K/AKT signalling pathway in patient-derived MM121224 cells harboring BRAF V600E/NRAS Q61K mutant coexpressing mutated forkhead box protein 1 allele fused mNeonGreen fluorophore incubated for 2 hrs | 2022 | Journal of natural products, 04-22, Volume: 85, Issue:4
| High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma. |
| AID1866561 | Inhibition of MAPK/ERK signalling pathway in patient-derived MM121224 cells harboring BRAF V600E/NRAS Q61K mutant coexpressing ERK-KTR fused mScarlett fluorophore incubated for 2 hrs by high-content screening microscopic analysis | 2022 | Journal of natural products, 04-22, Volume: 85, Issue:4
| High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma. |
| AID1866573 | Thermal stability of compound assessed as compound degradation at -80 to -20 degC measured after 15 months by HPLC-ELSD analysis | 2022 | Journal of natural products, 04-22, Volume: 85, Issue:4
| High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma. |
| AID1866558 | Inhibition of PI3K/AKT signalling pathway in human A2058 cells harbouring BRAF V600E and PTEN deletion mutant coexpressing mutated forkhead box protein 1 allele fused mNeonGreen fluorophore incubated for 2 hrs by high-content screening microscopic analysi | 2022 | Journal of natural products, 04-22, Volume: 85, Issue:4
| High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |